Recent Advances in Metallo-Drugs
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Molecular Structure".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 6396
Special Issue Editor
Interests: dendrimer chemistry; organic and organophosphorus chemistry; macromolecules for catalysis; nanomedicine and materials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
Since the discovery of the anticancer properties of cisplatin (cis-diamminedichloroplatinum (II)) in 1965 and its approval for clinical use in 1978, the investigation of metal complexes as anticancer chemotherapeutic agents has blossomed. Administration of platinum-based drugs has substantial adverse side effects (e.g., neurotoxicity) and is unable to prevent cancer relapse, and intrinsic or acquired resistance can develop in several types of cancer. Thus, many efforts have been made to develop metallo-drugs based on other metals, such as palladium, gold, ruthenium, copper, or osmium. Different types of ligands have also been developed, as well as vehicles to transport the metallo-drug to its targets. Furthermore, in addition to their anticancer properties, metallo-drugs are usable in other fields, for instance, as antibacterial agents.
The Special Issue of Molecules titled “Recent Advances in Metallo-Drugs” welcomes papers related to recent discoveries involving metal complexes in biology/medicine, particularly (but not only) as anticancer agents.
Prof. Dr. Anne-Marie Caminade
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metallo-drugs
- anticancer
- biological properties
- ligands
- transition metals
- noble metals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.